SelectION
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
655 India St Unit 204, San Diego, Califo...Phone Number
(858) 967-8014Revenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About SelectION
selectION Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for T cell-mediated autoimmune diseases. Their lead product, si-544, is a first-in-class Kv1.3 blocker that aims to modify the disease process by selectively deactivating disease-causing T cells while preserving healthy immune function. The company targets a wide range of autoimmune conditions, including psoriasis, rheumatoid arthritis, and multiple sclerosis, with the potential for significant therapeutic impact. By addressing the root cause of autoimmunity, selectION Therapeutics seeks to provide patients with durable disease modification and improved quality of life.Explore more
SelectION Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SelectION your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once SelectION has new funding data
SelectION, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when SelectION launches new products
Click to see if SelectION had a recent Job posting/layoffs
Check if SelectION has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at SelectION
Check out if SelectION is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on SelectION recently announced quarterly report
Recommended Actions
Find VP level buyers at SelectION
Find more new buyers
Compare Similar Companies to SelectION
Compare insights from companies similar to SelectION, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
SelectION is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SelectION is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SelectION.
SelectION financials insights
Gather financial insights about SelectION, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$41M
2025
Private Equity
$5.4M
SelectION Tech Stack
A closer look at the technologies used by SelectION
Most Recent Scoops
Funding
Funding
Event
Product Marketing, Events, Field /Outside Sales, Field Marketing
Funding
Funding
Funding
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SelectION
Sign Up For FreeTo access detailed company insights
selectION Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for T cell-mediated autoimmune diseases. Their lead product, si-544, is a first-in-class Kv1.3 blocker that aims to modify the disease process by selectively deactivating disease-causing T cells while preserving healthy immune function.... Read More
